fbpx
QQQ
-0.94
327.30
-0.29%
DIA
-1.94
313.81
-0.62%
SPY
-1.33
385.48
-0.35%
TLT
+ 0.49
150.90
+ 0.32%
GLD
-1.39
176.67
-0.79%

Today's Top 10 Pre-Makret Gainers

by
May 31, 2016 9:28 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Today's Top 10 Pre-Makret Gainers

Gainers for the Day

  • Celator Pharmaceuticals (NASDAQ: CPXX) was trading up 71.14% after Jazz Pharmaceuticals (NASDAQ: JAZZ) announced its plans to acquire the company for $30.25 a share in cash.
  • Cliffs Natural Recourses (NYSE: CLF) up 24.43% after JP Morgan upgraded the company to overweight with a price target of $7.00
  • Tata Motors Ltd (NYSE: TTM) rose 12.45% after beating earnings estimates yesterday.
  • Tonix Pharmaceuticals (NASDAQ: TNXP) jumped 4.80% after reporting positive results from Phase 2 AtEase Study of TNX 102-SL in PTSD
  • Intercept Pharmaceuticals (NASDAQ: ICPT) traded up 4.39% after FCC granted accelerated approval to Ocaliva for treatment of patients with PBC.
  • Cymabay Therapeutics (NASDAQ: CBAY) was trading up 8.64% after the company announced top line efficacy and safety data from its phase 2 study of Mbx-805
  • Amicus Therapeutics (NASDAQ: FOLD) up 5.38% after European Commission approved Galaford for patients with Fabry disease.
  • Westar Energy Inc (NASDAQ: WR) jumped 8.24% after Great Planes Energy (NYSE: GXP) announced acquiring the Westar for $51.00 cash and $9.00 stock per share.
  • Titan Pharmaceutics (NASDAQ: TTNP) up 7% after its Probuphine approval.
  • Sodastream International (NASDAQ: SODA) traded up 10.12% after announcing its home beer system.

Posted-In:

Pre-Market Outlook

Related Articles

The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 12) read more

Earnings Scheduled For November 5, 2020

  Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.64 per share on revenue of $52.59 million. read more

The Daily Biotech Pulse: Gilead Gets Full Approval For Remdesivir, Akebia's Positive Readout, Foghorn IPO

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 22) read more

12 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers Geovax Labs (NASDAQ:GOVX) stock increased by 1203.45% to $3.49 during Friday's pre-market session. The market value of their outstanding shares is at $48.2 million. read more